Lataa...
Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer
BACKGROUND: Targeted therapies, associated with standard chemotherapies, have improved breast cancer care. However, primary and acquired resistances are frequently observed and the development of new concepts is needed. High-throughput approaches to identify new active and safe molecules with or wit...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3445597/ https://ncbi.nlm.nih.gov/pubmed/23028451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0043409 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|